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The mode of action of PTHrP in the regulation of sea bream
(Sparus auratus) interrenal cortisol production was studied
in vitro using a dynamic superfusion system. Piscine (1–
34)PTHrP (106–1011 M) stimulated cortisol production in a
dose-dependent manner. The ED50 of (1–34)PTHrP was 2.8
times higher than that of (1–39)ACTH, andmaximum increase
in cortisol production in response to 108 M of (1–34)PTHrP
was approximately 7-fold lower than for 108 M of (1–39)ACTH.
In contrast to (1–34)PTHrP, piscine (10–20)PTHrP, (79–
93)PTHrP, and (100–125)PTHrP (109–107 M) did not stimu-
late cortisol production. The effect of piscine (1–34)PTHrP on
cortisol production was abolished by N-terminal peptides in
which the first amino acid (Ser) was absent and by simulta-
neous addition of inhibitors of the adenylyl cyclase-protein
kinase A and phospholipase C-protein kinase C intracellular
pathways but not by each separately. The PTHrP-induced
signal transduction was further investigated by measure-
ments of cAMP production and [H3]myo-inositol incorpora-
tion in an interrenal cell suspension. Piscine (1–34)PTHrP
increased cAMP and total inositol phosphate accumulation,
which is indicative that the mechanism of action of PTHrP in
interrenal tissue involves the activation of both the adenylyl
cyclase-cAMPandphospholipaseC-inositol phosphate signal-
ing pathways. These results, together with the expression of
mRNA for PTHrP and for PTH receptor (PTHR) type 1
and PTHR type 3 receptors in sea bream interrenal tissue,
suggest a specific paracrine or autocrine steroidogenic action
of PTHrP mediated by the PTHRs. (Endocrinology 146: 71–76,
2005)
PTHrP IS A protein that shares sequence similarity to theN terminus of PTH, a product of the parathyroid gland
and a key hormone in calcium metabolism in mammals.
PTHrP is a paracrine factor that is produced in a range of
different tissues and has a wide spectrum of biological ac-
tivity. Posttranslational processing of PTHrP, which contains
multibasic endoproteolytic sites (multi-K/R), has been
shown to give rise to amino-terminal, mid-region, and
carboxy-terminal mature secretory forms of PTHrP (1). The
processing pathways and activities of the various peptides
arising from PTHrP are still not fully characterized in mam-
mals and remain the subject of considerable study.
PTHrP has been identified in most vertebrate groups, in-
cluding teleost fish in which a PTHrP-like protein was iden-
tified in tissue and plasma, and subsequently, the cDNA and
gene were isolated from sea bream (Sparus auratus) and the
puffer fish (Fugu rubripes), respectively (2, 3). Moreover, a
PTH-like factor has also recently been identified in fish (4),
which shares 59% identity with PTHrP isolated from puffer
fish, sea bream, and flounder (Platichthys flesus). Multiple
sequence alignment of the amino acid sequence of PTHrP
from fish and mammals indicates that they share 52% iden-
tity in the N-terminal region [(1–34)PTHrP] (2), raising the
question of whether there is conservation of function.
PTHrP brings about its biological activity by binding to
the G protein-coupled, PTH receptor (PTHR), and stimu-
lates the adenylyl cyclase (AC)-cAMP and phospholipase
C (PLC)-inositol phosphate (IP) signaling pathways (5). Of
both the PTHRs cloned in human, only PTHR type 1
(PTH1R) responds to PTHrP and strongly activates the
AC-protein kinase A (PKA) signaling pathway and, to a
lesser extent, the PLC-protein kinase C (PKC)-intracellular
Ca2 signaling pathway (6). Recently, three different
teleost PTHRs [(PTH1R, PTHR type 2 (PTH2R), and PTHR
type 3(PTH3R)] were identified in zebrafish (Danio rerio),
and receptor activation was characterized in vitro (7, 8).
However, PTHRs have still not been isolated from any
other teleost, and the tissue distribution and binding char-
acteristics of the native receptors to fish PTHrP remains to
be characterized.
In mammals, PTHrP has recently been reported in various
tissues of the hypothalamus-pituitary-adrenal axis (9). The
interaction between hypothalamic CRH and pituitary ACTH
regulates cortisol production (10). Although a range of other
hormones and peptides also modulate this process, PTHrP
was recently shown to stimulate cortisol release from dis-
persed human adrenocortical cells (11). Moreover, in mam-
mals, glucocorticoids regulate the expression of the gene
encoding PTHrP (12). The teleost fish interrenal gland is
homologous to the mammalian adrenal gland, and in both,
the basic structure is made up of cords. However, whereas
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in mammals, a central medulla of chromaffin tissue is sur-
rounded by a zoned adrenal cortex, in fish, adrenocortical
cells are intermingled with chromaffin cells (13). The pe-
ripheral zona glomerulosa of the adrenal gland produces
aldosterone, whereas a zona fasciculate produces glucocor-
ticoids, including cortisol. Aldosterone is not commonly de-
tected in teleost fish (13). The presence of PTHrP in the brain,
pituitary gland, and interrenal tissue of the sea bream (2, 14)
raises questions about its potential involvement in control of
cortisol production in fish. In the present study, the capacity
of N-terminal peptides of piscine PTHrP to stimulate cortisol
release from sea bream interrenal tissue is established. To
characterize the corticotropic activity of PTHrP and the
amino acid residues important for receptor activation in this
tissue, several N-terminal truncated forms of piscine PTHrP
are used. The PTHR types present in piscine interrenal tissue
and the intracellular signaling mechanisms activated after
PTHR binding are established.
Materials and Methods
Chemicals
Piscine (1–34)PTHrP, (2–34)PTHrP, (3–34)PTHrP, (7–34)PTHrP, (10–
20)PTHrP, (79–93)PTHrP, and (100–125)PTHrP were synthesized
by Genemed Synthesis, Inc (San Francisco, CA). Human (1–39)ACTH,
corticotropin-inhibiting peptide (CIP), phosphodiesterase inhibitor (3-
isobutyl-1-methylxanthine, IMBX), PLC inhibitor (U-73122), BSA,MEM,
collagenase/dispase 2-phenoxyethanol, and other laboratory reagents
were purchased from Sigma-Aldrich (Madrid, Spain). SQ-22536, an AC
inhibitor, was obtained from Calbiochem (La Jolla, CA). The RIA kit for
cAMP and [H3]myo-inositol (specific activity, 629 GBq/mmol) were
purchased from Amersham Biosciences (Little Chalfont, UK), and an
in-house assay was used to measure cortisol.
Fish
Sexually immature gilthead sea bream (S. auratus), weighing 80–120
g, were maintained at the Ramalhete experimental station of the Uni-
versity of Algarve (Faro, Portugal) under constant environmental con-
ditions; the photoperiod was 14 h of daylight and 10 h of dark, and the
water temperature was 22 1 C. Fish were kept in 5 m3 seawater tanks
in an open circuit, which received a continuous flow (250 cm3h1) of
well-aerated seawater. Tanks were stocked at a density of 4 kgm3, and
fish were fed twice daily at 0900 h and 1800 h with 1% body weight
commercial dry pellets (PROVIMI, Lisbon, Portugal). Food was with-
held from fish for 24 h before sampling.
In vitro superfusion
All fish belonging to the same sampling groupwere rapidly captured
and anesthetized with an overdose of 2-phenoxyethanol (1:1000 vol/
vol). Intact head kidney was quickly dissected from each fish placed in
superfusion chambers and superfused with buffered HEPES Ringer
solution (HEPES, 15 mm; pH 7.38) containing NaCl (171 mm), KCl (2
mm), CaCl2/2H2O (2 mm), 0.25% (wt/vol) glucose, and 0.03% BSA
(wt/vol). This mediumwas pumped through the superfusion chambers
at a rate of 75 lmin1 by means of a multichannel peristaltic pump
(Masterflex; Cole-Palmer, Vernon Hills, IL) and fractions of 1.5 ml were
collected in ice. The whole system was maintained at a constant tem-
perature of 18C. Previous studieswith this system indicated that cortisol
reaches stable basal levels after 3 h of superfusion (14). Therefore, when
a steady basal state was reached, tissue was stimulated for 20 min with
the different treatments applied. To characterize the dose-response
curves of cortisol production for different regions of the PTHrP mole-
cule, the head kidney was perfused with the following peptides: Fugu
and flounder (1–34)PTHrP from 106–1012m; sea bream (10–20)PTHrP
from 107–109 m; sea bream (79–93)PTHrP from 107–109 m; and sea
bream (100–125)PTHrP from 107–109m. The overall cortisol synthetic
capacity of the head kidneywas determined by perfusing 108m human
(1–39)ACTH. The effect of N-terminal truncated forms of sea bream
PTHrP on cortisol production by the head kidney was determined by
comparing the production rates when perfusing with 108 m Fugu (1–
34)PTHrP, 108 m Fugu (2–34)PTHrP, 108 m Fugu (3–34)PTHrP, and
108m Fugu (7–34)PTHrP. To establish whether the cortisol stimulatory
activity of PTHrP was occurring through its binding to the ACTH
receptor or through binding to a PTHR, 108 m Fugu (1–34)PTHrP was
perfused alone or in the presence of 106 m of CIP, Fugu (2–34)PTHrP,
Fugu (3–34)PTHrP, and Fugu (7–34)PTHrP. In a final group of experi-
ments aimed at establishing the principal signaling pathway used by
PTHrP in the head kidney, Fugu (1–34)PTHrP (108 m) was used to
perfuse a head kidney preparation alone or in the presence of a PLC
inhibitor (104 m SQ-22536) and/or an AC inhibitor (105 m U-73122).
The cortisol released in the head kidney fractions was determined by
RIA and expressed as nanogram of cortisol per gram of head kidney per
hour or as percentage of basal release, considering as 100% basal the
release in the 30 min preceding the application of a stimulus.
Interrenal cell suspension
Thepreparation of an interrenal cell suspension for themeasurements
of cAMP and [H3]myo-inositol incorporation was carried out as previ-
ously described (15). In brief, the head kidney of individual fish was
removed and placed in a culture dish containing complete medium
(MEM supplemented with 5 gliter1 BSA; 2.2 gliter1 NaHCO3; 2
gliter1 NaCl, pH 7.4; 348 mosmol). The tissue was washed with com-
plete medium, resuspended in fresh complete medium containing 2
mgml1 collagenase/dispase, and incubated for 15 min with gentle
agitation. The solution was then filtered with a 60-m mesh cloth, and
the filtrate was centrifuged at 1500 rpm for 5 min. The pellet was
resuspended in complete medium, and the cells were counted using a
hemocytometer. Cell viability estimated by tryptan blue at the end of the
isolation procedure was 92  4.6%.
Measurement of cAMP production
To measure cAMP, isolated interrenal cells were plated into 24-well
sterile culture plates (Costar, Corning Incorporated, Corning, NY) at 2
106 cellswell1 in 1 ml complete medium. After 30 min of preincubation
in complete medium containing 1 mm IMBX, cells were incubated for an
additional 30-min period in complete medium-IMBX in the presence or
absence of 108 m Fugu (1–34)PTHrP or 108 m Fugu (7–34)PTHrP.
Culture plates were then centrifuged, the medium was aspirated, and
cells were resuspended in 0.01 m PBS with 4 mm EDTA. Subsequently,
the cells were sonicated, and aliquots were taken for protein determi-
nation. Thereafter, samples were boiled and centrifuged at 5000 rpm for
5 min at 4 C. The supernatant was removed and stored at20 C. cAMP
concentration was determined by RIA using a kit (TRK 432; Amersham
Biotrak). Results are reported as picomoles of cAMP per milligram of
total protein. Total protein was determined by the Lowry method (16).
Measurement of [H3]myo-inositol incorporation
[H3]myo-inositol incorporation was determined following the
method described by Ramirez et al. (17) with small modifications. In-
terrenal cells were plated in 24-well plates at 2 106 cellswell1 in 1 ml
complete medium. After 1 h of preincubation, cells were incubated for
30 min in complete medium containing [H3]myo-inositol (37 MBqml1;
specific activity, 629 MBqnmol1) in the presence or absence of 108 m
of Fugu (1–34)PTHrP or 108 m Fugu (7–34)PTHrP. The reaction was
stopped by centrifugation at 2500 rpm at 4 C and by suspending the
pellet in 500 l ice-cold 10% trichloroacetic acid. The contents were
transferred from 24-well culture plates into 1.5-ml microtubes and son-
icated. An aliquot was taken for total protein determination, and the
remainder was centrifuged at 12,000 rpm for 15 min at 4 C. The super-
natant, containing IPs, was removed and measured in a scintillation
counter (LS6100; Beckman Coulter, Fullerton, CA). Chloroform-meth-
anol (2:1, vol/vol) was then added to the pellet to extract the phospho-
inositide phosphates (PIPs). After centrifugation at 12,000 rpm for 15min
at 4 C, this supernatant was also removed and counted. Counts obtained
for IPs and PIPs were pooled, and the results reported corresponded to
the total amount of [H3]myo-inositol incorporated in each sample (phos-
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phoinositides plus PIPs) and are expressed as counts per minute per
milligram protein.
RT-PCR of PTHrP and PTHRs
Sea bream head kidneys were collected and immediately frozen in
liquid nitrogen. Total RNA was extracted with TRI reagent (Sigma-
Aldrich, St. Louis, MO), and the final concentrationwasmeasured using
a spectrophotometer (GeneQuant; Amersham Biosciences, Lisbon, Por-
tugal). The quality of extracted total RNA was determined by agarose
gel (1.5%) electrophoresis. cDNA synthesis was carried out by adding
the following to each reaction tube: 1.25 l oligo dT (1 g l1; Amer-
sham Biosciences); 2 l of 5 RT buffer (Life Technologies, Inc.-BRL,
Barcelona, Spain); 0.25 l of MMLV Reverse transcriptase (200 U l1;
Life Technologies, Inc.-BRL); 0.5 l deoxynucleotide triphosphate (10
mm; AmershamBiosciences), and 1l dithiothreitol (0.1m). The reaction
was allowed to proceed for 3 h at 37 C and was then stopped by heating
at 65 C for 5 min and stored at 20 C until use. For the RT-PCRs, 1 l
of cDNA was added to a reaction mixture (50 l) containing 10 mm
Tris-HCl (pH 9.0), 50 mm KCl, 0.1% Triton X-100, 2 mmMgCl2, 0.2 mm
deoxynucleotide triphosphate, 1.25 U Taq DNA polymerase (Promega,
Madison, WI), and 10 pmol each of forward and reverse primers for the
gene of interest. The sea bream PTHrP specific sense primer (5-GAAT-
TCAGGAGGTCAGTGAGCCAC-3) and antisense primer (5-AACA-
GACCGTGCCCGCCTCCTCTTCTTGTC-3) yielded a 359-bp product.
The sea bream PTH1R specific sense primer (5-GCGGCAGTAACA-
CATACAGC-3) and antisense primer (5-TTTCTCTTTCCTCCTC-
CACC-3) yielded a 290-bp product. The sea breamPTH3R specific sense
primer (5-ACATCCACATTCACTTCTTCAC-3) and antisense primer
(5-GATGAGGGCCACAGGTAGT-3) yielded a 274-bp product. As a
positive control, plasmids containing cloned PTH1R and PTH3R sub-
stituted cDNA in the PCR. Elongation factor 1 was used as a control
to establish the relative quantity of cDNAused in each reaction (18). PCR
products were visualized by ethidium bromide staining after electro-
phoresis on 1.5% agarose gels. The bands were excised, purified with
GFX PCR DNA and Gel Band Purification Kit (Amersham Biosciences),
cloned into pGem-T-easy plasmid, and used to transform competent
Escherichia coli. Plasmid DNA was prepared from recombinant E. coli
using the alkaline lysis method (19) and sequenced (Macrogen Inc.,
Seoul, South Korea). DNA sequence analyses were performed using
BLAST (20). GenBank accession numbers for sea bream PTHrP, PTH1R,
and PTH3R are AF197904, AJ619024, and AY547261, respectively.
Biochemical analysis
Cortisol was determined in head kidney perfusate using a cortisol
RIA. The cross-reactivity of this antiserum in relation to cortisol was 54%
for 11-desoxycortisol, 10% for cortisone, 16% for 17,21-dihydroxy-5-
pregnan-3,11,20-trione, 5% for 11,17,21-trihydroxy-5-pregnan-3,20-
dione, 0.05% for 11-hydroxytestosterone, and less than 0.001% for tes-
tosterone. Head kidney perfusates (15 l) were diluted in phosphate
buffer (300 l) containing 0.5 gl1 gelatin (pH 7.6) and denatured at 70
C for 30 min.
Data analysis
Results are presented as mean  sem of six separate head kidney
perfusions. Data analysis was carried out using one-way ANOVA fol-
lowed by the Student-Newman-Keuls test. When nonhomogeneous
variances were found, the Mann-Whitney and Kruskal-Wallis test were
applied. The level for accepted statistical significance was P  0.05.
Significant differences in the figures are indicated with asterisks (*, P 
0.05; **, P 0.01; and ***, P 0.001). Standard curve analysis was carried
out with the PharmacologyModule of Sigma Plot, version 8.0 (SPSS Inc.,
Chicago, IL), by fitting of a four-parameter logistic function.
Results
Of all the piscine PTHrP peptides tested, only the intact
Fugu and flounder N-terminal fragment (1–34)PTHrP stim-
ulated, in a dose-dependent fashion, the in vitro release of
cortisol from isolated sea bream interrenal glands (Fig. 1).
The baseline secretion established for control tissue was
7.41 nm. The time lag between application of the piscine
(1–34)PTHrP stimulus and the increase in cortisol production
by the interrenal tissue was similar to that observed when
ACTHwas used to stimulate tissue (both occurred within 20
min). This is indicative that piscine (1–34)PTHrP has a rapid
stimulatory action on cortisol production by interrenal tissue
in fish. Truncated forms of Fugu (1–34)PTHrP, in which the
first amino acid (2–34), first two amino acids (3–34), or first
six amino acids (7–34) were removed, failed to stimulate
cortisol release from head kidney (Fig. 2A). These results
indicate that amino-terminal deletions of teleost PTHrP af-
fect the ability of these truncated forms to stimulate in vitro
cortisol release from interrenal tissue.
The way in which PTHrP brings about its stimulatory
action on cortisol production by interrenal tissue was as-
sessed in a series of experiments with specific inhibitors.
Piscine (1–34)PTHrP (108m)-stimulated cortisol production
from interrenal tissue was unaffected by 106 m CIP. In
contrast, CIP effectively blocked 90% of ACTH corticotropic
activity (data not shown). This suggests that the PTHrP effect
is not mediated by its binding to an ACTH receptor. How-
ever, the stimulatory effect of (1–34)PTHrP could be removed
by co-perfusionwith 106m of any of the truncated peptides,
including (7–34)PTHrP, which is known to act as an antag-
onist by binding to the PTHR. This is indicative that PTHrP
binds to a PTHR in the head kidney. Supporting the existence
of such receptor(s) is the demonstration by RT-PCR that sea
bream interrenal tissue expresses PTHrP and two PTHRs,
PTH1R and PTH3R (Fig. 3). Overall, these results strongly
suggest that PTHrP most likely brings about its effect on
cortisol production by binding to specific PTHRs.
To establish which of the receptors and/or signaling path-
ways ismediating the PTHrP-stimulated cortisol production,
the effect of AC (104m SQ-22536) and PLC (105mU-73122)
inhibitors was investigated. When either of the inhibitors
was added to sea bream interrenal tissue in vitro in the
FIG. 1. Effect of increasing doses of Fugu (1–34)PTHrP, flounder
(1–37)PTHrP, and sea bream (10–20)PTHrP, (74–93)PTHrP, and
(100–125)PTHrP on the in vitro release of cortisol from superfused
sea bream head kidney. Data are given as percentage of basal release
and represent the mean  SEM of six independent determinations.
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presence of piscine (1–34)PTHrP (108 m), no significant in-
hibition of cortisol release was obtained. However, with the
simultaneous addition of both inhibitors, 104 m SQ-22536
and 105 m U-73122, the stimulation of cortisol release from
sea bream interrenal tissuewas totally abolished (Fig. 4). This
is indicative that both the AC and PLC pathways can be used
to bring about PTHrP corticosteroidogenic response. cAMP
release and [H3]myo-inositol incorporation by dispersed in-
terrenal cells was stimulated 2.5- and 1.8-fold, respectively,
by piscine (1–34)PTHrP (108m) (Fig. 5). The truncated forms
of (2–34)PTHrP and (3–34)PTHrP failed to stimulate cAMP
release and [H3]myo-inositol incorporation (data not shown),
whereas (7–34)PTHrP significantly increased (P  0.05)
[H3]myo-inositol incorporation but not cAMP release (Fig. 5).
This indicates that the first seven amino acids of the N ter-
minus of piscine PTHrP are important for optimal AC-cAMP
signaling pathway activation, but the PTHrP activation of the
PLC-IP signaling pathway is more complex.
Discussion
The results from the present study demonstrate that
PTHrP has corticosteroidogenic activity in fish and the
ligand determinants of receptor signaling in interrenal
cells. Piscine (1–34)PTHrP stimulated cortisol release in a
concentration-dependent manner in interrenal tissue of
sea bream. The ED50 of (1–34)PTHrP was 2.8 times higher
than that of (1–39)ACTH (14), and the percent increase of
cortisol production in response to 108 m of (1–34)PTHrP
was approximately 7-fold lower than for 108 m of
(1–39)ACTH. In contrast to (1–34)PTHrP, piscine (10–20)-
PTHrP, (79–93)PTHrP, and (100–125)PTHrP failed to
stimulate corticosteroidogenesis at 109–107m. The effect
of piscine (1–34)PTHrP was abolished by N-terminal pep-
tides in which the first amino acid (Ser) was absent and by
inhibitors of the AC and PLC intracellular pathways.
These results, together with the expression of mRNA for
PTHrP and for PTH1R and PTH3R receptors in sea bream
interrenal tissue, suggest that this is a specific effect me-
diated by PTHRs, and as observed in mammals (1, 21), this
is indicative of a paracrine or autocrine effect of PTHrP
modulating corticosteroid production in this tissue (22).
FIG. 3. Amplified products of specific RT-PCR for sea bream PTHrP,
sea breamPTH1R, and sea breamPTH3R using cDNA prepared from
sea bream head kidney mRNA. RT-PCR products were fractionated
on a 1.5% agarose gel and stained with ethidium bromide. EF-1,
Elongation factor 1.
FIG. 4. Effect of AC inhibitor SQ-22536 (104 M) and PLC inhibitor
U-73122 (105 M) on (1–34)PTHrP (108 M)-stimulated cortisol se-
cretion from sea breamhead kidneys. Head kidneyswere treatedwith
peptides and/or inhibitors for 20 min. Data represent the mean SEM
of six independent experiments. Asterisks indicate significant differ-
ence from (1–34)PTHrP only.
FIG. 2. A, Effect of ACTH (108 M) and intact or truncated forms of
(1–34)PTHrP (108 M) on in vitro cortisol secretion from superfused
sea breamhead kidneys. B, Effect of CIP (106 M) and truncated forms
of (1–34)PTHrP (106 M) on (1–34)PTHrP (108 M)-stimulated in vitro
cortisol secretion from superfused sea bream head kidneys. Head
kidneys were treated with peptides for 20 min. Data represent the
mean  SEM of six independent experiments. Asterisks indicate sig-
nificant difference from control basal release (A) and PTHrP only (B).
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The possibility that the cortisol stimulatory activity of
(1–34)PTHrP in interrenal tissue was a result of direct inter-
action with the ACTH receptor was eliminated because CIP,
at concentrations that effectively abolish ACTH-stimulated
cortisol release in interrenal tissue, had no effect on (1–
34)PTHrP-induced cortisol production. This demonstrated
unequivocally that piscine (1–34)PTHrP stimulates cortisol
release via another mechanism and is in agreement with a
glucocorticoid secretagogue effect reported for (1–34)PTHrP
in human adrenal cells in vitro (5). This indicates that the
glucocorticoid secretagogue action of the N terminus of
PTHrP has been conserved during evolution.
In the present study, amino-terminal deletions in teleost
PTHrP, such as removal of the first residue (2–34), first two
residues (3–34), or first six residues (7–34), caused a dramatic
reduction in the biological potency of (1–34)PTHrP. This
suggests that, in fish, the first seven amino acids and, in
particular, the first Ser of the N terminus of piscine PTHrP
are determinants of the glucocorticoid secretagogue activity.
A similar observation has beenmade in humans, inwhich the
cortisol stimulatory action of human (1–34)PTHrP was abol-
ished by the PTHR antagonist (Leu11, d-Trp12)PTHrP (7–34)-
amide. The importance of an intact N-terminal region of
PTHrP for biological activity appears to be a general phe-
nomenon, and amino acid deletions have been observed to
reduce its potency in cAMP second messenger responses of
COS-7 cells expressing zebrafish PTHRs (6).
In mammals, PTH and PTHrP are both expressed in the
hypothalamus and pituitary gland, whereas PTHRs have
been found in all components of the hypothalamus-pituitary-
adrenal axis (9). In common with this observation, PTHrP is
produced by a variety of endocrine and nonendocrine tissues
in fish (2, 3, 22, 23). For example, PTHrP and its mRNA have
been demonstrated in the brain, pituitary, and head kidney
of sea bream (2, 3, 22). Furthermore, very high to moderate
concentrations of immunoreactive PTHrP have been de-
tected, in decreasing order of abundance, in extracts of pi-
tuitary, head kidney, esophagus, intestine, gill, skin, and
muscle of the sea bream (22). The high pituitary and circu-
lating levels of this hormone measured in the sea bream and
flounder may indicate that in teleosts, in contrast to what is
observed in mammals, PTHrP, in addition to paracrine and
autocrine actions, can also act as an endocrine factor (22, 24).
In mammals, two principal PTHR types have been iden-
tified, PTH1R and PTH2R (25, 26). Characterization of
ligand-binding affinity indicates that PTH1R binds equally
well to human PTHrP and human PTH, whereas PTH2R
binds preferentially to bovine tuberoinfundibular peptide
(TIP39) (27). PTH1R is the receptor most frequently charac-
terized in nonskeletal tissue, which interacts with amino-
terminal fragments of PTHrP (28, 29). There are relatively
few studies describing PTHRs inmammalian adrenals.How-
ever, those studies indicate that in common with other non-
skeletal tissue the receptor expressed in the adrenals is
PTH1R (30). The identification in the sea bream interrenal
tissue of two receptors, a mammalian PTH1R analog and
PTH3R, which has so far only been described in fish, raises
questions about the relative importance of these receptors in
the responsiveness of the head kidney to PTHrP. Further
studies will be required to elucidate the role of these two
receptors in the regulation of cortisol production in fish.
In vitro studies of zebrafish PTH1R and PTH3R expressed
in COS-7 cells reveal that zebrafish PTH1R was similarly
activated by human PTH, human PTHRP, and Fugu PTHrP.
Conversely, zebrafish PTH3R showed higher affinity for hu-
man PTHrP and Fugu PTHrP (7, 8).
Until recently, all evidence suggested that PTHRs signal
principally via the AC-PKA signaling pathway and second-
arily via the PLC-PKC-intracellular Ca2 signaling pathway
(6). The previously mentioned zebrafish COS-7 cells trans-
fection studies established that zebrafish PTH1R and PTH2R
grouped with isolated mammalian receptors. However, the
fish-specific receptor, zebrafish PTH3R, activated the AC-
PKA signaling pathway but not the PLC-PKC-intracellular
Ca2 signaling pathway (8). In the present study, PTHrP-
stimulated cortisol production from the head kidney was
only completely blocked when inhibitors to both pathways
were used, indicating that most likely PTH1R, which signals
via both pathways (AC-PKA and PLC-PKA), is the receptor
involved. However, it has not been possible to confirm or
determine the relative importance of PTH1R and/or PTH3R
in the PTHrP-stimulated cortisol response, and no informa-
tion about the functional importance of these receptors in fish
is available. One observation for which we do not have a
good explanation is that, although (7–34)PTHrP was able to
inhibit cortisol and cAMP production, it did not appear to be
effective in blocking the PLC-PCK pathway. One possibility
is that partial blockage of each pathway is enough to block
cortisol production, as indicated by the effect of SQ-22536
and U-73122 inhibitors, which only block cortisol when both
are used together. The precise ligand regions of (1–34)PTHrP
involved in the stimulation of PLC and PKC have not yet
been clearly identified. However, it has been shown that
(1–31)PTH stimulates AC but not PLC inmouse kidney cells,
indicating that the C-terminal amino acids of (1–34)PTHrP
are involved in the activation (31). However, replacing Glu19
for Arg19 in human (1–28)PTH restored PLC signaling and
FIG. 5. Effect of (1–34)PTHrP (108 M) and (7–34)PTHrP (108 M) on
cAMP production (A) and on incorporation of [H3]myo-inositol (B) by
dispersed sea bream interrenal cells. Cells were challenged for 30min
in the presence of IMBX. Data represent the mean  SEM of two
independent determinations in three separate experiments.Asterisks
indicate significant difference from control.
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ligand-binding affinity, and (1–28)PTH is the shortest human
PTH peptide that could fully activate both AC and PLC.
Furthermore, PLC activity was reduced by substituting Gly1
for Ser1 in human (1–34)PTH and was eliminated entirely by
removing either residue 1 or the -amino group alone. Thus
it has been concluded that the N-terminal determinants of
AC and PLC activation in human PTH(1–34) overlap but are
not identical (32). Our results with piscine PTHrP peptide are
consistent with the observations made with PTH in human.
In summary, the present study clearly shows that (1–
34)PTHrP behaves as a glucocorticoid secretagogue in inter-
renal tissue. The stimulatory effect of N-terminal PTHrP is
not caused by its binding to ACTH receptors but probably
occurs via activation of PTH1RandPTH3R, both ofwhich are
expressed by sea bream interrenal tissue. Upon ligand bind-
ing, both the AC-PKA and PLC-PKC-intracellular Ca2 sig-
naling pathways are activated in interrenal tissue, leading
ultimately to increased cortisol production. The corticoste-
roidogenic effect of the N-terminal region of PTHrP appears
to have been conservedduring evolution because it is present
in both fish and mammals, although the physiological rele-
vance of this effect remains to be established. It appears that
the paracrine action reported for PTHrP and other members
of the glucagon family in mammalian adrenals (9) can be
extended to the homologous interrenal tissue of the sea
bream and possibly other teleosts.
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